Search
Every article we have published, filed by the company it is actually about.
1260 articles about companies over $2B
@BillRoman15 I'm looking at '27 numbers, which gives $FIS and $GPN a full year of owning TSYS+Worldpay. But whatever metric I look at, fwd P/E, FCF or sales looks ballpark similar for the 3. Which honestly makes it a little hard for me to even own $GPN after the pop over buying more $FIS.
@BillRoman15 So my point is and has been for a while that I don't get why people would go with a massive turnaround in Fiserv, when you can get the same exposure but better fundamentals, mngmt with a track record (can debate if good or bad!) with $GPN + $FIS AND withot paying up
BHP 2026-08-20 
On the Pulse 1 click ANET 2026-08-20 
The Curious Analyst @Adam17609412325 @BillRoman15 Earnings quality legit? Say what? Doing $40/share isn't a high hurdle for $GPI to clear next year (even if they stumbled on the used car side in Q2 and might have a bit of a rebranding headwind in H2 '26).
@THESAVAGEJOHNSO It's the biggest shitco in a sector full of shitcos. Can get the same exposure with $GPN + $FIS at about the same price, but they already focused their businesses, grow MSD and in a much better spot. $FISV can't hold on to neither execs nor customers, why bother
SA 2026-08-20 
Redfern Research @BillRoman15 Not sure I follow... I also own $GPN and thinks it is great value despite a nice pop...
@DueDoctor Oh I agree 100%. The move is totally insane. $GME like. +20% would have made some sense based on math. I actually think lack of 2ndary here is even WORSE for them. They need the cash. 2ndary cleans up that need.
$MRNA any basis to think this can make it as a monotherapy or just combination drug?
@DueDoctor All goes well this could add $800mn in annual revenue to $mrna. Added $44B in market cap. Market said that theoretical 2-3 year out revenue is worth 50x + yesterdays' market cap
@Jono8325 @MLedrappier @roadkillrecipes @CalgaryLeveen @FishOnCapital $NN Someone asked my opinion. I provided it. I am sorry if it makes you frustrated that things often take longer than we expect. It has been my life experience that things take longer than expected. That said, I am very positive on the next couple of months with NN.
Good report from $BULL. I remain long and may add. https://t.co/mvOiOAN83t
The question needs to be asked: Why haven't $META and $GOOG done more to control the narrative around data center construction? They literally can amplify whatever news, posts, and videos they want. We've learned that. Don't tell me they've learned their lesson about meddling (there's a $1T+ court case ongoing that tells me otherwise). Instead we're hearing narratives about China and Tiktok, when two MAJOR AI players own the pipes that serve every other social media post and video in this country. It's a strange set of circumstances. Would $GOOG and $META benefit if @AnthropicAI and @openAI go through the windshield? Of course, but it's not obvious how a backlash against data centers helps these hyperscalers otherwise. Thoughts?
Norwegian Cruise Line’s $15 billion debt and 2026-27 capex delay deleveraging, despite fuel-efficient new ships and stronger projected 2028…
@BoxLongs $SNAP added $250mn in revenue yy and $200mn in adj ebitda. Adj shares outstanding actually decreased 70 bps yy. FCF +400% yy. While everyone knows its a horribly managed asset, the numbers in isolation are MUCH improved YoY while stock itself is down 30% yy.
@SandBrandyn I bought a basket of software and adjacent in Feb/March. $TEAM most ridiculous example both to the down and now upside... I don't trust the management teams enough to make a concentrated bet on any of these.
$mrna secondary coming in 21.05 minutes
Atlassian $TEAM now up 214% since April, and +5% YTD. Market very efficiently determining future discounted cash flows from software companies, I see.
@LocalHero55 @OtterMarket @gatorcapital Post on an even more obscure MHC bank. And yes, $TFSL is a great income instrument, with (eventually) a chunky cap gain exit when they finally convert.
Continue to believe that expiration this week will be the culmination in the software squeeze. Money will want to come off the table ahead of earnings season for the sector, and I think that will be followed with an acknowledgment from earnings that while their revenues are not at risk today - these companies still do face increased competition, lower barriers, higher costs for cloud/inference, and seat based model problems that will be challenging moving forward. The $WDAY rumor news was not the floor, it was the peak counter narrative to AI disruption.
Impressive just how many healthcare companies with no direct or derivative exposure today or at any point to the $MRNA news can rally 10%+ on the day. Be smart for these companies to pocket these gains with secondaries and solidify fragile balance sheets, but in the ultimate short term pump market their management teams will no doubt not want to interrupt their stocks squeeze potential and will not issue shares, but aggressively unload their options
If you buy the $SNDK Dec 2028 1560 Straddle the stock would have to drop below $30 to make money on the downside
@OtterMarket @gatorcapital $tfsl is just under a billion when you exclude the phantom shares. I've owned it a long time and very few people care about it either. That said, this NY one is even more obscure
